NALOXONE HYDROCHLORIDE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 51662-1586
  • Package NDC 51662-1586-1
  • Package NDC 51662-1586-3
  • Application number ANDA213279
  • SPL ID 0ffa7c10-a9fe-7701-e063-6394a90a06cf
  • SPL set ID e65e03c1-9a66-b30b-e053-2995a90aeb73
  • UNII F850569PQR
  • RxCUI 1191250

What the source publishes

Labeler
HF Acquisition Co LLC, DBA HealthFirst
Active ingredients
NALOXONE HYDROCHLORIDE
Form
INJECTION, SOLUTION
Routes
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:51662-1586_0ffa7c10-a9fe-7701-e063-6394a90a06cf
{
  "name": "NALOXONE HYDROCHLORIDE",
  "splId": "0ffa7c10-a9fe-7701-e063-6394a90a06cf",
  "labels": [
    {
      "setId": "e65e03c1-9a66-b30b-e053-2995a90aeb73",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e65e03c1-9a66-b30b-e053-2995a90aeb73",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e65e03c1-9a66-b30b-e053-2995a90aeb73"
    }
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS",
    "SUBCUTANEOUS"
  ],
  "labeler": "HF Acquisition Co LLC, DBA HealthFirst",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE in 1 BOX (51662-1586-1)  / 2 mL in 1 SYRINGE",
      "package_ndc": "51662-1586-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220816"
    },
    {
      "sample": false,
      "description": "10 POUCH in 1 CASE (51662-1586-3)  / 1 BOX in 1 POUCH (51662-1586-2)  / 1 SYRINGE in 1 BOX / 2 mL in 1 SYRINGE",
      "package_ndc": "51662-1586-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220816"
    }
  ],
  "productId": "51662-1586_0ffa7c10-a9fe-7701-e063-6394a90a06cf",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "51662-1586",
  "deaSchedule": null,
  "genericName": "NALOXONE HYDROCHLORIDE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NALOXONE HYDROCHLORIDE",
      "strength": "1 mg/mL"
    }
  ],
  "applicationNumber": "ANDA213279",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220816",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "F850569PQR"
    ],
    "rxcui": [
      "1191250"
    ],
    "spl_set_id": [
      "e65e03c1-9a66-b30b-e053-2995a90aeb73"
    ],
    "manufacturer_name": [
      "HF Acquisition Co LLC, DBA HealthFirst"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:51662-1586_0ffa7c10-a9fe-7701-e063-6394a90a06cf"